The United States buys nearly all global supply of remdesivir for coronavirus treatment

By Jim Campbell

July 2nd, 2020

President Trump is damned if he does and damned if he doesn’t.

He took an oath to protect The U.S. Constitution and Bill of Rights and the citizens who live here.

It’s time for the leftist media who are trying to make this their next claim to fame to lighten up.

The drug manufactured by Gilead Sciences has been shown to help moderately ill COVID-19 patients recover more quickly from the disease. By Joseph Guzman | July 1, 2020

The Trump administration announced this week the U.S. struck an agreement with Gilead to secure more than 500,000 treatment courses of the drug for American hospitals through September.

Gilead will sell 100 percent of its supply for July to the U.S. and 90 percent of the supply produced in August and September.

The move by the U.S., however, leaves a large part of the world without access to the drug.

The U.S. has bought nearly the entire global supply of the antiviral drug remdesivir, the only treatment licensed to treat COVID-19, as the nation continues to experience surging cases of coronavirus. 

The drug manufactured by Gilead Sciences has been shown to help moderately ill COVID-19 patients recover more quickly from the disease and was granted temporary approval for coronavirus patients by the Food and Drug Administration (FDA) in early May. 

The Trump administration announced this week the U.S. struck an agreement with Gilead to secure more than 500,000 treatment courses of the drug for American hospitals through September. 

Remdesivir will be sold for $520 per vial in the U.S., or $3,120 per treatment course, to hospitals for treatment of patients with private health insurance, according to the Department of Health and Human Services (HHS) and Gilead Sciences.

The price will be set at $2,340 per treatment course for patients on government-sponsored insurance and for those in countries with national health care systems. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” Health and Human Services Secretary Alex Azar said in a statement.

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people,” Azar said. 

Gilead will sell 100 percent of its supply for July to the U.S. and 90 percent of the supply produced in August and September. 

The move by the U.S., however, leaves a large part of the world without access to the treatment. 

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” Andrew Hill, a senior visiting research fellow at Liverpool University, told The Guardian.  

“This is the first major approved drug, and where is the mechanism for access? Once again we’re at the back of the queue,” he said. 

Ohid Yaqub, a senior lecturer at the University of Sussex, called it disappointing news. 

“It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said, according to the Associated Press (AP). 

Hill told The Guardian that the UK could get access to remdesivir through a compulsory license, which overrides the intellectual property rights of the company.

This would allow the UK to purchase from generic companies in Bangladesh or India where Gilead’s patent is not recognized.

Gilead Sciences is allowing generic manufacturers in 127 poor or middle-income countries to supply the drug. 

The U.S. currently leads the world in coronavirus cases, with more than 2.6 million confirmed and  512,000 deaths, according to Johns Hopkins University data. 

Brazil has the second-highest number of cases worldwide with more than 1.4 million, followed by Russia with more than 653,000.

India has tallied more than 585,000 and the UK more than 314,000. 

Was the U.S. being selfish buying up Gilliad Sciences biological?

Please leave your comments in the comment section below. Thanks.

THE END

About JCscuba

I am firmly devoted to bringing you the truth and the stories that the mainstream media ignores. Together we can restore our constitutional republic to what the founding fathers envisioned and fight back against the progressive movement. Obama nearly destroyed our country economically, militarily coupled with his racism he set us further on the march to becoming a Socialist State. Now it's up to President Trump to restore America to prominence. Republicans who refuse to go along with most of his agenda RINOs must be forced to walk the plank, they are RINOs and little else.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.